跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PROTHROMBINEX-VF human prothrombin complex powder for injection vial and diluent vial - TGA Drug Approval Details
Approvals
/
TGA
/
PROTHROMBINEX-VF human prothrombin complex powder for injection vial and diluent vial
Approved
STANDARD
PROTHROMBINEX-VF human prothrombin complex powder for injection vial and diluent vial
CSL Behring (Australia) Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
d25757e6cf30e524
Company
CSL Behring (Australia) Pty Ltd
Type
Standard
Approval Details
Approval Id
d25757e6cf30e524
Product Name
PROTHROMBINEX-VF human prothrombin complex powder for injection vial and diluent vial
Artg Id
124381
Artg Name
PROTHROMBINEX-VF human prothrombin complex powder for injection vial and diluent vial
Sponsor
CSL Behring (Australia) Pty Ltd
Company Detail Path
/organization/csl-behring-australia-pty-ltd
Artg Date
2006-01-30
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/7be9cb0f29076cd21f943da56e5b80cc.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/185cecb814f9d1511ba07994d6c6e024.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
d25757e6cf30e524
Type
Standard
Back to TGA Approvals